| 2.1 |
6.2 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.0 |
11.4 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.8 |
4.2 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.6 |
2.3 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.5 |
1.9 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.4 |
3.0 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.3 |
1.6 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.3 |
4.8 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.3 |
2.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.3 |
0.9 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.3 |
0.9 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.3 |
2.2 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.3 |
2.8 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.3 |
1.3 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.2 |
1.0 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.2 |
2.4 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
0.9 |
GO:2001137 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) positive regulation of endocytic recycling(GO:2001137) |
| 0.2 |
0.7 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.2 |
1.9 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.2 |
0.9 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.2 |
0.5 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.2 |
0.9 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.1 |
1.5 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
2.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
2.0 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.1 |
2.5 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 |
1.3 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
0.6 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.1 |
1.2 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.3 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.1 |
0.6 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 |
0.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.1 |
0.3 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 |
0.2 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
1.3 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.7 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
0.3 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
0.2 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
0.3 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.1 |
0.5 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
1.2 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.6 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.0 |
0.6 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.0 |
6.7 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
0.2 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.0 |
0.1 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.0 |
1.0 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.0 |
0.5 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) regulation of high voltage-gated calcium channel activity(GO:1901841) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.9 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.0 |
0.5 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.0 |
0.2 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.1 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.0 |
0.4 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.5 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.6 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
1.1 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.3 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
0.5 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 |
0.5 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.4 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.0 |
2.2 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.0 |
0.3 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.8 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.0 |
0.2 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 |
0.6 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.1 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.0 |
0.1 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.0 |
0.4 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.7 |
GO:0055010 |
ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.0 |
0.6 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.9 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.0 |
GO:0021553 |
establishment of blood-nerve barrier(GO:0008065) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) olfactory nerve development(GO:0021553) negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 |
0.5 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.0 |
0.4 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.3 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 |
0.1 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) |
| 0.0 |
0.1 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.0 |
0.0 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 |
0.1 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
